Okayama, Japan

Kotaro Suto

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Okayama University. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kotaro Suto. Retrieved from https://idiyas.com/inventor/kotaro-suto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kotaro Suto: Innovator in Chemical Production

Introduction

Kotaro Suto is a notable inventor based in Okayama, Japan. He has made significant contributions to the field of chemistry, particularly in the production of pharmaceutical compounds. His innovative approach has led to advancements that enhance the efficiency and safety of chemical processes.

Latest Patents

Kotaro Suto holds a patent for a "Nitro group-containing ether compound and method for producing same." This invention allows for the safe and stable production of oseltamivir in large quantities. The process utilizes tartaric acid, mannitol, or arabinose as starting materials, which are transformed via a dihydroxyhexenoic acid ester. This method represents a significant improvement in the synthesis of important pharmaceutical compounds.

Career Highlights

Suto is affiliated with Okayama University, where he conducts research and develops innovative chemical processes. His work has garnered attention for its practical applications in the pharmaceutical industry. With a focus on enhancing production methods, he continues to contribute to advancements in chemical engineering.

Collaborations

Some of his notable coworkers include Seiki Saito and Takayuki Kudoh. Their collaborative efforts have furthered research initiatives and fostered innovation within their field.

Conclusion

Kotaro Suto's contributions to chemical production exemplify the impact of innovative thinking in the pharmaceutical industry. His patent and ongoing research highlight the importance of developing safer and more efficient methods for producing essential compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…